Six months ended June 30, | |||||||||||||
In millions of Euros | 2016 IFRS | Adjustment |
2016
|
2015 IFRS | Adjustment |
2015
|
|||||||
Cost of revenue | (231.0) | 1.4 | (229.6) | (217.0) | 0.3 | (216.7) | |||||||
Research and development | (269.2) | 13.9 | (255.3) | (251.6) | 4.4 | (247.2) | |||||||
Marketing and sales | (460.0) | 11.8 | (448.2) | (445.7) | 4.1 | (441.6) | |||||||
General and administrative | (110.4) | 6.9 | (103.5) | (100.9) | 1.9 | (99.0) | |||||||
Total share-based compensation expense | 34.0 | 10.7 |
(2) The non-IFRS percentage increase (decrease) compares non-IFRS measures for the two different periods. In the event there is non-IFRS adjustment to the relevant measure for only one of the periods under comparison, the non-IFRS increase (decrease) compares the non-IFRS measure to the relevant IFRS measure. (3) Based on a weighted average 257.3 million diluted shares for H1 2016 and 255.9 million diluted shares for H1 2015.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160720006542/en/